SCHEDULE: Invus Group Discloses 8% Stake in Scholar Rock

Invus Public Equities, L.P. and affiliated entities have reported beneficial ownership of 8.0% of Scholar Rock Holding Corporation's common stock as of June 30, 2026.

Summary

• Invus Public Equities, L.P. and its affiliates (collectively, the 'Reporting Persons') have filed a Schedule 13G, indicating their beneficial ownership of 9,575,013 shares of Scholar Rock Holding Corporation's common stock.
• This ownership stake represents 8.0% of the company's outstanding common stock.
• The filing is an amendment (Amendment No. 10) and the event date requiring the filing is June 30, 2026.
• The Reporting Persons include Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Invus Global Management, LLC, Siren, L.L.C., and Mr. Raymond Debbane.
• The shares outstanding used for calculation were 119,828,338 as of May 4, 2026, as reported in Scholar Rock's Form 10-Q filed on May 7, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is a routine Schedule 13G filing disclosing beneficial ownership and does not contain new operational or financial performance information.

Positives

• Significant institutional ownership by Invus Group, potentially indicating confidence in Scholar Rock's long-term prospects.
• Clear disclosure of beneficial ownership, adhering to regulatory requirements.

Negatives

• The filing itself does not provide new operational or financial performance data, making it difficult to assess current company health from this document alone.

Risks

• Potential for future changes in beneficial ownership by the Reporting Persons, which could impact share price or corporate control.
• The concentration of ownership could lead to significant influence over corporate decisions.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future performance.

Management Comments

• The Reporting Persons certify that the securities were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer, nor in connection with any transaction having that purpose or effect, other than in connection with a nomination under Rule 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in biotechnology companies like Scholar Rock. Such filings often precede or coincide with periods of increased investor interest or strategic shifts within the sector.

Comparison to Industry Standards

• As a Schedule 13G filing, it adheres to standard SEC disclosure requirements for significant beneficial ownership.
• The 8.0% ownership stake is a substantial but not controlling interest, typical for large institutional investors in the biotech sector.
• The reporting structure involving multiple affiliated entities is a common practice for investment management firms.

Stakeholder Impact

• Shareholders: May view the increased institutional ownership positively, potentially leading to greater liquidity or strategic focus, but also raises questions about potential future influence on corporate decisions.
• Management: May need to engage with Invus Group regarding their investment strategy and the company's direction.
• Creditors: The filing does not directly impact creditors, but any significant change in company strategy influenced by large shareholders could indirectly affect credit risk.

Next Steps

• Monitoring future filings from Invus Group for any changes in their beneficial ownership.
• Observing Scholar Rock Holding Corporation's strategic developments and financial performance for insights into the company's valuation and prospects.

Key Dates

Keywords

Scholar Rock Holding Corporation, Schedule 13G, Beneficial Ownership, Invus Group, Institutional Investor, Common Stock, SEC Filing